Open access · CC-BY
via OpenAlex
Telomerase gene therapy: a novel approach to combat aging
EMBO Molecular Medicine · 2012 · ▲ 48 citations
Abstract
Telomeres are repetitive DNA sequences located at the very ends of our chromosomes. Together with specific proteins, they form a cap like structure that prevents the cells from sensing the linear chromosome ends as ‘damaged’. Like a burning fuse, telomeres progressively shorten with every cell division and, depending on cell type, initiate either apoptosis or trigger a permanent proliferative arrest, termed cellular senescence(definition), once a critical length is reached. It is thought that this cell division countdown timer developed as a tumour suppressing mechanism to prevent precancerous cells from proliferating indefinitely. While we currently do not know how efficient this tumour suppressing mechanism is in humans, numerous studies using mouse models have demonstrated that critically short and dysfunctional telomeres indeed present a powerful barrier to cancer growth (Artandi & DePinho, 2010).
Unfortunately, this tumour suppressing mechanism also comes at a cost. As we age, telomeres in most of our tissues progressively become shorter and therefore likely contribute to the failure of our organs and tissues observed in old age. Supporting this are data demonstrating that healthy lifespan is positively correlated with longer telomeres in humans, and patients suffering from age‐related diseases and premature aging syndromes display shorter telomeres compared to healthy individuals (Zhu et al, 2011). Furthermore, cells with damaged telomeres accumulate in some tissues of aging mice and nonhuman primates, supporting the model that telomere(definition) shortening and the resulting senescence response promotes aging in mammals (Fumagalli et al, 2012; Herbig et al, 2006; Hewitt et al, 2012). Indeed, preventing the accumulation of senescent cells in aging mice significantly improves healthspan(definition), demonstrating that cellular senescence, regardless of its induction, is a cause of aging associated disorders (Baker et al, 2011).
Certain cells within our tissues have the ability to stabilize telomere lengths more efficiently than others. …
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/emmm.201200246
- Canonical
- link ↗
- Fetched
- 2026-11-13 MST
Cite this
APA
Boccardi, V., & Herbig, U. (2012). Telomerase gene therapy: a novel approach to combat aging. <em>EMBO Molecular Medicine</em>. https://doi.org/10.1002/emmm.201200246
Vancouver
Boccardi V, Herbig U. Telomerase gene therapy: a novel approach to combat aging. EMBO Molecular Medicine. 2012. doi:10.1002/emmm.201200246.
BibTeX
@article{virginia2012Telome,
title = {Telomerase gene therapy: a novel approach to combat aging},
author = {Virginia Boccardi and Utz Herbig},
journal = {EMBO Molecular Medicine},
year = {2012},
doi = {10.1002/emmm.201200246},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Experimental Cell Research 2002
Citation only
Telomere Biology and Cellular Aging in Nonhuman Primate Cells
Journal of Urological Surgery 2016
Open access · CC-BY
Re: Role of Telomeres and Telomerase in Cancer
Research Journal of Pharmacy and Technology 2017
Citation only
Telomere-A Short Review
Aging Cell 2009
Citation only
DNA damage response and cellular senescence in tissues of aging mice
Aging 2019
Preprint · CC-BY
Telomerase gene therapy ameliorates the effects of neurodegeneration associated to short telomeres in mice
FEBS Letters 1998
Open access · OA